Operator
Good afternoon, ladies and gentlemen, thank you for standing by. Welcome to the CytomX Therapeutics Fourth Quarter and Full Year 2020 Financial Results Call. Please be advised that today s call is being recorded.
I would now like to hand the conference over to your host for today, Chau Cheng, CytomX s Vice President, Investor Relations and Corporate Communications. Please go ahead.
Chau Cheng
Vice President, Investor Relations and Corporate Communications
Thank you, Victor. Good afternoon, and thank you for joining us. With me today are Dr. Sean McCarthy, CytomX s President, Chief Executive Officer and Chairman; Dr. Amy Peterson; Chief Development Officer; and Carlos Campoy, Chief Financial Officer. Earlier today, we issued a press release that includes a summary of our fourth quarter and full year 2020 financial and highlights the important progress we made during the year. We encourage everyone to read today s press release and the associated materials, which have
San-antonio
Texas
United-states
Sean-mccarthy
Halley-gilbert
Robert-burns
Carlos-campoy
Terence-flynn-goldman-sachs
Chau-cheng
Probody
Amyc-peterson
Seana-mccarthy